The preset invention relates to {HEAD ~ a biomarker} for identifying {TAIL ~ the subgroup} of early stage lung adenocarcinoma patients in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated protein kinase , and a therapeutic target for lung cancer 
for identifying
The preset invention relates to { HEAD ~ a biomarker } for identifying { TAIL ~ the subgroup } of early stage lung adenocarcinoma patients in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated protein kinase , and a therapeutic target for lung cancer
OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH